Healthcare professionals usually encounter challenges to address the health conditions facing female patients. In light of the changing nature of today’s society, chronic and acute illnesses among women have become more prevalent. The prevalence of such illnesses is attributable to the unique health issues and conditions that women experience in their day-to-day life. While some of these health conditions affect men too, they are more severe among women. Given the unique health conditions, women experience chronic and acute illnesses that affect their overall health and wellbeing. Some of the chronic and acute health conditions affecting women include urinary tract infections and osteoporosis. This paper examines the management of these two conditions through comparison of common and non-traditional treatment modalities.
Urinary Tract Infection and Osteoporosis
A urinary tract infection is defined as an infection involving organs that create urine and carry it out of the human body (Harvard Health Publishing, 2017). Some of these organs or structures include ureters, bladder, kidneys, and urethra. Urinary tract infections are classified into two i.e. lower tract infections and upper tract infections. Lower tract infections are infections of the bladder that are commonly known as cystitis whereas upper tract infections are infections involving kidneys and ureters. While urinary tract infections affect both men and women, they are more common in women because they have short urethras that enable relatively easy movement of bacteria into the bladder.
On the contrary, osteoporosis is a condition that weakens the bones and enhances the risk of unexpected and sudden fractures. Such fractures emerge because the condition results in increased loss of bone strength and mass. In most cases, this condition progresses without pain or any symptoms. As a result, this condition is considered a silent disease that contributes to mortality and morbidity across the globe. According to Carbone et al. (2015), osteoporosis is a major public health issue, especially for women. Currently, the prevalence rates of osteoporosis among women in the United States is estimated at 10%. Postmenopausal women account for a significant percentage of women suffering from osteoporosis at 9.65% (Tian, 2017). It is estimated that 12.3 million people aged 50 years or more in the United States will suffer from osteoporosis by 2020 (U.S. Preventive Services Task Force, 2018).
It is estimated that the prevalence of urinary tract infections has increased by 70% over the past two decades. This prevalence has occurred across all age groups and racial/ethnic groups, especially in women (Carbone et al., 2015). Currently, at least one-third of adult women are reported to have experienced at least one episode of symptomatic lower tract infection at least once. In addition, between 10%-13% of women in the United States experience a urinary tract infection each year with a lifetime risk of 50% (Eells et al., 2014). As a result, urinary tract infections among women in the United States contribute to more than 6 million outpatient visits and 479,000 hospitalizations each year.
Treatment of these two conditions is critical because of their contributions to morbidity and mortality in the United States and around the world. Urinary tract infections among women not only affect their quality of life, but are linked with societal costs of treatment that exceed $2.46 billion each year (Eells et al., 2014). In addition, recurrent urinary tract infections have become a major problem in clinical practice. On the other hand, osteoporosis is a major contributor of common metabolic diseases and the major cause of mortality and morbidity in the elderly population.
Health Promotion and Screening
Public health professionals recognize the significance of treatment of urinary tract infection and osteoporosis among women. Consequently, the public health sector has adopted various initiatives to help prevent...
Pharmacology Case StudiesScenario 1: Mary\\\'s Hypothyroidism ManagementProblem DescriptionMary, aged 35, has been diagnosed with hypothyroidism, as evidenced by an elevated Thyroid-Stimulating Hormone (TSH) level of 20. Alongside, she suffers from iron deficiency anemia, as indicated by low MCV, MCHC, Ferritin, and high Total Iron Binding Capacity (TIBC) values. Her current regimen includes non-prescription Kelp tablets, ibuprofen as needed, and a contraceptive pill.Medication PrescriptionGiven Mary�s high TSH levels and symptoms, I
Initial tests may be culdocentesis, hematocrit, a pregnancy test, a qualitative HCG blood test, a transvaginal ultrasound or pregnancy ultrasound and a white blood count test. An ectopic pregnancy can be distinguished from a normal intrauterine pregnancy through a rise in quantitative HCG levels. Declining B-hCG levels is indicative of an ectopic pregnancy (Kulp & Barnhart 2008). AD & C, laparoscopy and laparotomy tests will confirm the diagnosis (Chen). An
Prescription, Nonprescription and Herbal Medicines Prescription, Non-prescription and Herbal Medications: Exploring Interactions in the Geriatric Population Geriatric medicine, generally referred to as just "geriatrics" is a branch of internal medicine and health care that focuses primarily on the diagnoses, prevention, care and treatment of disease and disability in elderly patients. Elderly patients involve those senior members of the population that develop a disability, or are suffering from a disease that is a
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now